Dr. Avital Harari, MD

Dr. Harari practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Harari's NPI, 1831349935, was assigned on September 25, 2008. Dr. Harari graduated from David Geffen School of Medicine at UCLA in 2022. Dr. Harari holds California license A107125.

Dr. Harari's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Harari's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Harari is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Associated General Surgeons. Dmand AI also links Dr. Harari to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harari practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Harari's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Harari is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Harari's licenses on file in 2 states: California and New York.

Dmand AI lists thyroid surgery among the conditions Dr. Harari treats.

CMS data shows 301 Medicare services from Dr. Harari across 7 procedure codes in 2024, for 112 Medicare patients. Medicare paid $52,443 for them.

CMS counts 112 Medicare patients who saw Dr. Harari in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Harari's median patient age at 59, with 71% women.

In 2024, Dr. Harari wrote 23 Medicare Part D claims for 15 patients. 78% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $171 in total drug cost. In 2017, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Harari for performance year 2024, reported as part of a group. Dr. Harari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harari as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Harari, published from 2012 to 2021. 2012 was the busiest year, with 5. Dr. Harari's most frequent co-authors are Kevin Ro, Amer Abdulla, MD and Nancy L. Ascher, MD.

CMS Open Payments shows 3 general payments to Dr. Harari from 3 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Exelixis Inc. paid the most, $87.

Dmand AI lists 10 awards for Dr. Harari, most recently Superdoctor Southern California Rising Star (2013,2014,2015) in 2015.

Dr. Harari graduated from David Geffen School of Medicine at UCLA in 2022. Dr. Harari is a member of American Associationof Clinical Endocrinologists, AACE, American Association of Endocrine Surgeons, ACS, American Medical Women's Association and American Thyroid Association.

Dr. Harari is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.